Abbvie to acquire Allergan for $63 billion
AbbVie Corporate Headquarters (Credit: © AbbVie Inc. All rights reserved.)
Abbvie has agreed to buy Irish drugmaker Allergan, with Kirkland & Ellis and Weil Gotshal & Manges advising on antitrust.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10